Published on 8 March 2022
Description:
Unleashing the power of medical affairs, Takeda looks at the challenges facing combination treatments, MHRA: COVID-19 vaccines, treatments and tests
Categories:
Pharmaceutical Market EuropePreview:
30 articles from this collection:
PME December 2021
2 - SAMEDAN
3 - Comment
4 - COMMUNIQUE AWARDS 2022
5 - Contents
6-7 - News
6-7 - PME - Pharma Market Europe Pharmaceutical News
8 - News
9 - Health technology assessments
10-11 - Coronavirus news
12 - FANTASY SEMINAR
12 - Pharma Market Europe Darwin’s medicine
13 - IS COVID_19 OVER?
The technology responses to this pandemic have fallen far short of expectations
14 - WHICH PATIENT?
15 - CREATING LIFE CYCLE STRATEGIES FOR THE FUTURE OF YOUR TEAM'S SUCCESS
16-17 - The challenges facing combination treatments
18-19 - COVID-19 vaccines, treatments and tests
20-22 - Meeting with the FDA: valuing the statistician and preparing for review
18-19 - Empowering patients empowers results
23 - Into the metaverse
24-26 - Pharma: the customer experience
27 - MARCH Highlights
28-29 - Medical Affairs
30 - The evolution of medical affairs
31 - The changing face of the medical science liaison
32-33 - Navigating the maze of modern medical affairs
34-35 - The experts within
36-37 - Strategic cultures
38-40 - Appointments
41 - HEALTHCARE COMMS
42 - The Innovation Gateway opens at The London Cancer Hub
43 - Recruitment
43 - Pharma Market Europe (PME) Recruitment
44 - T40
Pharmaceutical Market Europe (PME)
Pharmaceutical industry news, articles, jobs, reports, advice and services